Mostra el registre parcial de l'element
dc.contributor.author | Sarideechaigul, W. | es |
dc.contributor.author | Priprem, A. | es |
dc.contributor.author | Limsitthichaikoon, S. | es |
dc.contributor.author | Phothipakdee, P. | es |
dc.contributor.author | Chaijit, R. | es |
dc.contributor.author | Jorns, Teekayu P. | es |
dc.contributor.author | Lungruammit, N. | es |
dc.contributor.author | Chaiya, K. | es |
dc.date.accessioned | 2023-05-31T12:29:19Z | |
dc.date.available | 2023-05-31T12:29:19Z | |
dc.date.issued | 2021 | es |
dc.identifier.citation | Sarideechaigul, W., Priprem, A., Limsitthichaikoon, S., Phothipakdee, P., Chaijit, R., Jorns, T. P., Lungruammit, N., & Chaiya, K. (2021). Efficacy and safety of two artificial saliva-based polymers containing 0.1% pilocarpine for treatment of xerostomia: A randomized clinical pilot trial. Journal of clinical and experimental dentistry, 13(10), e994–e1000. | es |
dc.identifier.uri | https://hdl.handle.net/10550/87350 | |
dc.description.abstract | Topical agents are the mainstay in the treatment of xerostomia, a common complaint most frequently associated with salivary dysfunction. This study aimed to compared the efficacy and safety for xerostomia treatment of 2 artificial saliva preparations containing 0.1% pilocarpine, and, either sodium carboxymethylcellulose (SCMC), or, sodium polyacrylate (SPA). | es |
dc.title | Efficacy and safety of two artificial saliva-based polymers containing 0.1% pilocarpine for treatment of xerostomia : a randomized clinical pilot trial | es |
dc.type | journal article | es_ES |
dc.subject.unesco | UNESCO:CIENCIAS MÉDICAS | es |
dc.identifier.doi | 10.4317/jced.58415 | es |
dc.type.hasVersion | VoR | es_ES |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501859/ |